Megan Maher

Dr. Megan Maher

orcid

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 April 2006 in Journal of the American Chemical Society
Verified
Journal Article
Closed access
LZLianyi Zhang
Lianyi Zhang
MKMelissa Koay
Melissa Koay
MMMegan Maher
Megan Maher
ZXZhiguang Xiao
Zhiguang Xiao
AWAnthony G. Wedd
Anthony G. Wedd

3 March 2015 in Nature Communications
Verified
Journal Article
Open access
PDF file
SBStephanie L. Begg
Stephanie L. Begg
BEBart Eijkelkamp
Bart Eijkelkamp
ZLZhenyao Luo
Zhenyao Luo
RCRafael Couñago
Rafael Couñago
JMJacqueline R. Morey
Jacqueline R. Morey
CMChristopher A. McDevitt
Christopher A. McDevitt
Cadmium is a transition metal ion that is highly toxic in biological systems. Although relatively rare in the Earth’s crust, anthropogenic release of cadmium since industrialization has increased biogeochemical cycling and the abundance of the ion in the biosphere. Despite this, the molecular basis of its toxicity remains unclear. Here we combine metal-accumulation assays, high-resolution structural data and biochemical analyses to show that cadmium toxicity, in Streptococcus pneumoniae, occurs via perturbation of first row transition metal ion homeostasis. We show that cadmium uptake reduces the millimolar cellular accumulation of manganese and zinc, and thereby increases sensitivity to oxidative stress. Despite this, high cellular concentrations of cadmium (~17 mM) are tolerated, with negligible impact on growth or sensitivity to oxidative stress, when manganese and glutathione are abundant. Collectively, this work provides insight into the molecular basis of cadmium toxicity in prokaryotes, and the connection between cadmium accumulation and oxidative stress.

9 July 2015 in Human Molecular Genetics
Verified
Journal Article
Open access
PDF file
DSDavid Arthur Stroud
David Arthur Stroud
MMMegan Maher
Megan Maher
CLCaroline Lindau
Caroline Lindau
FVF.-Nora Vögtle
F.-Nora Vögtle
AFAnn Frazier
Ann Frazier
MRMichael T. Ryan
Michael T. Ryan
Biogenesis of complex IV of the mitochondrial respiratory chain requires assembly factors for subunit maturation, co-factor attachment and stabilization of intermediate assemblies. A pathogenic mutation in COA6, leading to substitution of a conserved tryptophan for a cysteine residue, results in a loss of complex IV activity and cardiomyopathy. Here, we demonstrate that the complex IV defect correlates with a severe loss in complex IV assembly in patient heart but not fibroblasts. Complete loss of COA6 activity using gene editing in HEK293T cells resulted in a profound growth defect due to complex IV deficiency, caused by impaired biogenesis of the copper-bound mitochondrial DNA-encoded subunit COX2 and subsequent accumulation of complex IV assembly intermediates. We show that the pathogenic mutation in COA6 does not affect its import into mitochondria but impairs its maturation and stability. Furthermore, we show that COA6 has the capacity to bind copper and can associate with newly translated COX2 and the mitochondrial copper chaperone SCO1. Our data reveal that COA6 is intricately involved in the copper-dependent biogenesis of COX2.

14 February 2004 in Biochemistry
Verified
Journal Article
Closed access
MMMegan Maher
Megan Maher
MGMousumi Ghosh
Mousumi Ghosh
AGAmy M. Grunden
Amy M. Grunden
AMAngeli L. Menon
Angeli L. Menon
MAMichael Adams
Michael Adams
JGJ. Mitchell Guss
J. Mitchell Guss

4 September 2012 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
MIMomi Iwata
Momi Iwata
YLYang Lee
Yang Lee
TYTetsuo Yamashita
Tetsuo Yamashita
TYTakao Yagi
Takao Yagi
SISo Iwata
So Iwata
MMMegan Maher
Megan Maher
Bioenergy is efficiently produced in the mitochondria by the respiratory system consisting of complexes I–V. In various organisms, complex I can be replaced by the alternative NADH-quinone oxidoreductase (NDH-2), which catalyzes the transfer of an electron from NADH via FAD to quinone, without proton pumping. The Ndi1 protein from Saccharomyces cerevisiae is a monotopic membrane protein, directed to the matrix. A number of studies have investigated the potential use of Ndi1 as a therapeutic agent against complex I disorders, and the NDH-2 enzymes have emerged as potential therapeutic targets for treatments against the causative agents of malaria and tuberculosis. Here we present the crystal structures of Ndi1 in its substrate-free, NAD + - and ubiquinone- (UQ2) complexed states. The structures reveal that Ndi1 is a peripheral membrane protein forming an intimate dimer, in which packing of the monomeric units within the dimer creates an amphiphilic membrane-anchor domain structure. Crucially, the structures of the Ndi1–NAD + and Ndi1–UQ2 complexes show overlapping binding sites for the NAD + and quinone substrates.

2 September 2004 in The EMBO Journal
Verified
Journal Article
Open access
PDF file
JDJanet E Deane
Janet E Deane
DRDaniel P Ryan
Daniel P Ryan
MSMargaret Sunde
Margaret Sunde
MMMegan Maher
Megan Maher
JGJ Mitchell Guss
J Mitchell Guss
JMJacqueline M Matthews
Jacqueline M Matthews
Nuclear LIM‐only (LMO) and LIM‐homeodomain (LIM‐HD) proteins have important roles in cell fate determination, organ development and oncogenesis. These proteins contain tandemly arrayed LIM domains that bind the LIM interaction domain (LID) of the nuclear adaptor protein LIM domain‐binding protein‐1 (Ldb1). We have determined a high‐resolution X‐ray crystal structure of LMO4, a putative breast oncoprotein, in complex with Ldb1‐LID, providing the first example of a tandem LIM:Ldb1‐LID complex and the first structure of a type‐B LIM domain. The complex possesses a highly modular structure with Ldb1‐LID binding in an extended manner across both LIM domains of LMO4. The interface contains extensive hydrophobic and electrostatic interactions and multiple backbone–backbone hydrogen bonds. A mutagenic screen of Ldb1‐LID, assessed by yeast two‐hybrid and competition ELISA analysis, identified key features at the interface and revealed that the interaction is tolerant to mutation. These combined properties provide a mechanism for the binding of Ldb1 to numerous LMO and LIM‐HD proteins. Furthermore, the modular extended interface may form a general mode of binding to tandem LIM domains.